Vivacta's high-sensitivity piezofilm platform opens to partnering prospects
This article was originally published in Clinica
Executive Summary
Flush with the proceeds from a recent $12m series B financing, Vivacta is stepping up plans to launch into the point-of-care diagnostics market the first piezofilm sensor-based test.